CY1121708T1 - Ενωσεις ουριας ινδανυλιου που αναστελλουν την ρ38 map kιναση - Google Patents
Ενωσεις ουριας ινδανυλιου που αναστελλουν την ρ38 map kινασηInfo
- Publication number
- CY1121708T1 CY1121708T1 CY20191100626T CY191100626T CY1121708T1 CY 1121708 T1 CY1121708 T1 CY 1121708T1 CY 20191100626 T CY20191100626 T CY 20191100626T CY 191100626 T CY191100626 T CY 191100626T CY 1121708 T1 CY1121708 T1 CY 1121708T1
- Authority
- CY
- Cyprus
- Prior art keywords
- inhibit
- map kinase
- urea compounds
- indanyl
- indanyl urea
- Prior art date
Links
- WAQCADIPNPIBPZ-UHFFFAOYSA-N 2,3-dihydro-1h-inden-1-ylurea Chemical class C1=CC=C2C(NC(=O)N)CCC2=C1 WAQCADIPNPIBPZ-UHFFFAOYSA-N 0.000 title abstract 2
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 title 1
- 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 title 1
- 102000043136 MAP kinase family Human genes 0.000 abstract 1
- 108091054455 MAP kinase family Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Η παρούσα αίτηση σχετίζεται με παράγωγα της ουρίας ινδανυλίου που αναστέλλουν την Ρ38 ΜΑΡΚ και τη μέθοδο παρασκευής, φαρμακευτικής σύνθεσης και χρήσης για την παρασκευή του φαρμάκου στη θεραπεία των φλεγμονωδών νόσων όπως οι ασθένειες των αεραγωγών.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2772MU2014 | 2014-08-29 | ||
| PCT/IB2015/056505 WO2016030852A1 (en) | 2014-08-29 | 2015-08-27 | P38 map kinase inhibiting indanyl urea compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1121708T1 true CY1121708T1 (el) | 2020-07-31 |
Family
ID=55398832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20191100626T CY1121708T1 (el) | 2014-08-29 | 2019-06-18 | Ενωσεις ουριας ινδανυλιου που αναστελλουν την ρ38 map kιναση |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9963463B2 (el) |
| EP (1) | EP3186232B1 (el) |
| BR (1) | BR112017003930A2 (el) |
| CA (1) | CA2958410A1 (el) |
| CY (1) | CY1121708T1 (el) |
| DK (1) | DK3186232T3 (el) |
| ES (1) | ES2731429T3 (el) |
| HR (1) | HRP20191031T1 (el) |
| HU (1) | HUE044630T2 (el) |
| LT (1) | LT3186232T (el) |
| MY (1) | MY190027A (el) |
| PH (1) | PH12017500323B1 (el) |
| PL (1) | PL3186232T3 (el) |
| PT (1) | PT3186232T (el) |
| RS (1) | RS58889B1 (el) |
| SG (1) | SG11201701174VA (el) |
| SI (1) | SI3186232T1 (el) |
| TR (1) | TR201908937T4 (el) |
| WO (1) | WO2016030852A1 (el) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS58889B1 (sr) * | 2014-08-29 | 2019-08-30 | Torrent Pharmaceuticals Ltd | Jedinjenja indanil uree koja inhibiraju p38 map kinazu |
| WO2020113094A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2760012B1 (fr) | 1997-02-26 | 2000-08-18 | Oreal | Compositions pour la teinture des fibres keratiniques contenant des para-aminophenols, procede de teinture, nouveaux para-aminophenols et leur procede de prepraration |
| WO1998057937A2 (en) | 1997-06-19 | 1998-12-23 | The Du Pont Merck Pharmaceutical Company | Inhibitors of factor xa with a neutral p1 specificity group |
| US20080300281A1 (en) | 1997-12-22 | 2008-12-04 | Jacques Dumas | Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas |
| UA73492C2 (en) | 1999-01-19 | 2005-08-15 | Aromatic heterocyclic compounds as antiinflammatory agents | |
| EP1480973B1 (en) | 2002-02-25 | 2008-02-13 | Boehringer Ingelheim Pharmaceuticals Inc. | 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| CN101636397B (zh) | 2007-04-13 | 2012-06-13 | 中国人民解放军军事医学科学院毒物药物研究所 | 脲类化合物、其制备方法及其医药用途 |
| WO2011124923A2 (en) | 2010-04-08 | 2011-10-13 | Respivert Limited | Novel compounds |
| RS58889B1 (sr) * | 2014-08-29 | 2019-08-30 | Torrent Pharmaceuticals Ltd | Jedinjenja indanil uree koja inhibiraju p38 map kinazu |
-
2015
- 2015-08-27 RS RS20190731A patent/RS58889B1/sr unknown
- 2015-08-27 SG SG11201701174VA patent/SG11201701174VA/en unknown
- 2015-08-27 HU HUE15766935 patent/HUE044630T2/hu unknown
- 2015-08-27 SI SI201530780T patent/SI3186232T1/sl unknown
- 2015-08-27 ES ES15766935T patent/ES2731429T3/es active Active
- 2015-08-27 WO PCT/IB2015/056505 patent/WO2016030852A1/en active Application Filing
- 2015-08-27 DK DK15766935.9T patent/DK3186232T3/da active
- 2015-08-27 BR BR112017003930A patent/BR112017003930A2/pt active Search and Examination
- 2015-08-27 PL PL15766935T patent/PL3186232T3/pl unknown
- 2015-08-27 PT PT15766935T patent/PT3186232T/pt unknown
- 2015-08-27 LT LTEP15766935.9T patent/LT3186232T/lt unknown
- 2015-08-27 US US15/505,902 patent/US9963463B2/en active Active
- 2015-08-27 CA CA2958410A patent/CA2958410A1/en not_active Abandoned
- 2015-08-27 TR TR2019/08937T patent/TR201908937T4/tr unknown
- 2015-08-27 MY MYPI2017700567A patent/MY190027A/en unknown
- 2015-08-27 EP EP15766935.9A patent/EP3186232B1/en active Active
-
2017
- 2017-02-22 PH PH12017500323A patent/PH12017500323B1/en unknown
-
2019
- 2019-06-07 HR HRP20191031TT patent/HRP20191031T1/hr unknown
- 2019-06-18 CY CY20191100626T patent/CY1121708T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201701174VA (en) | 2017-03-30 |
| CA2958410A1 (en) | 2016-03-03 |
| BR112017003930A2 (pt) | 2018-03-06 |
| HUE044630T2 (hu) | 2019-11-28 |
| RS58889B1 (sr) | 2019-08-30 |
| EP3186232B1 (en) | 2019-03-27 |
| US9963463B2 (en) | 2018-05-08 |
| PH12017500323A1 (en) | 2017-07-10 |
| PT3186232T (pt) | 2019-06-24 |
| DK3186232T3 (da) | 2019-07-01 |
| PH12017500323B1 (en) | 2017-07-10 |
| HRP20191031T1 (hr) | 2019-08-23 |
| LT3186232T (lt) | 2019-07-10 |
| PL3186232T3 (pl) | 2019-10-31 |
| US20170247390A1 (en) | 2017-08-31 |
| ES2731429T3 (es) | 2019-11-15 |
| WO2016030852A1 (en) | 2016-03-03 |
| TR201908937T4 (tr) | 2019-07-22 |
| EP3186232A1 (en) | 2017-07-05 |
| MY190027A (en) | 2022-03-22 |
| SI3186232T1 (sl) | 2019-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124998T1 (el) | Ετεροκυκλικες ενωσεις και χρήσεις αυτων | |
| CY1124729T1 (el) | Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου | |
| CY1124726T1 (el) | Παραγωγα κιναζολινης που χρησιμοποιουνται για την αντιμετωπιση του hiv | |
| CY1122730T1 (el) | 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων | |
| CY1122695T1 (el) | Αλας toy omecamtiv mecarbil και διαδικασια για την παρασκευη αλατος | |
| CY1121843T1 (el) | Σκευασματα ετανερσεπτης σταθεροποιημενα με ιοντα μαγνησιου | |
| CY1121928T1 (el) | Φαρμακευτικη συνθεση υδροχλωρικης s-κεταμινης | |
| CY1122098T1 (el) | Παραγωγα ισοχρωμενιου ως αναστολεις κινασων φωσφοϊνοσιτιδης-3 | |
| EA201692301A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| MY196909A (en) | Boronic acid derivatives and therapeutic uses thereof | |
| ECSP17016797A (es) | Indazoles sustituidos con benzilo como inhibidores de bub1 | |
| EA201691988A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| EA201892838A1 (ru) | Новые пиперидинильные производные, способ их получения и фармацевтические композиции, содержащие их | |
| EA201600204A1 (ru) | Производные хиназолина, фармацевтическая композиция на их основе и их применение для профилактики или лечения опухоли | |
| UA116648C2 (uk) | Фумарати як проліки та їх застосування при лікуванні різних захворювань | |
| UY36175A (es) | 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas | |
| EA201592238A1 (ru) | Ингибиторы протеинкиназы pi3k, в частности ингибиторы pi3k дельта и/или гамма | |
| TR201909447T4 (tr) | Aramkol tuzları. | |
| EA201692313A1 (ru) | Производные индолизина в качестве ингибиторов фосфоинозитид-3-киназ | |
| EA201600124A1 (ru) | Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
| CY1120759T1 (el) | Παρασκευη διγλυκοζιτη (s,s)-σεκοϊσολαρικιρεσινολης και διγλυκοζιτη (r,r)-σεκοϊσολαρικιρεσινολης | |
| CL2014000849A1 (es) | Compuestos derivados de benzilindazoles sustituido, inhibidores de la quinasa bub1; procedimiento de fabricacion; composicion farmaceutica; combinacion farmaceutica; y su uso en el tratamiento de enfermedades hiperproliferativas. | |
| BR112015029462A8 (pt) | Inibidores de quinase | |
| EA201790650A1 (ru) | Лекарственная форма и способы применения абиратерона ацетата | |
| EA201691918A1 (ru) | Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения |